Arc Therapy Radiosurgery Faster Than Gamma Knife Treatments
By MedImaging International staff writers Posted on 03 Dec 2014 |
Volumetric modulated arc therapy (VMAT) radiosurgery treatments can be optimized to treat multiple brain metastases at the same time, according to a new study.
Researchers at the University of Alabama at Birmingham (UAB; USA) identified 20 previously treated Gamma Knife (GK) cases involving a total of 112 lesions, and re-planned them using single fraction VMAT RapidArc radiosurgery. The approach is based on using key RapidArc features, including a high-definition multileaf collimator for ultra-fine beam shaping; a high intensity mode for delivering high doses quickly; and jaw tracking technology for extra shielding of normal tissues.
The UAB approach to RapidArc planning calls for the beam to be delivered using non-coplanar arcs or rotations to maximize the number of treatment angles and enhance precision, as well as optimization criteria that minimizes the amount of low dose fall-off reaching normal brain tissues during treatment. The researchers also developed a predictive model of the 12Gy isodose volume as a function of tumor number and volume.
The results showed that the RapidArc treatment plans for treating multiple tumors are comparable to GK plans in terms of how precisely they can match high doses to the shape of the targeted tumors, as well as minimizing exposure of normal brain tissue outside the treatment area. The researchers also noted that RapidArc treatment for multiple metastases can be completed in 22 minutes, while a comparable GK treatment might take one to five hours, depending on the number of metastases. The study was published in the October 2014 issue of Neurosurgery.
“Brain metastases impact some 170,000 cancer patients in the US each year, and over 70% of those cases involve multiple metastases,” said senior author Prof. John Fiveash, MD, vice chairman for academic programs at UAB. “Using Varian's latest medical linear accelerators and RapidArc technology for VMAT, we can devise treatments that offer the same level of conformity as Gamma Knife technology.”
The RapidArc Radiosurgery system, a product of Varian Medical Systems (Palo Alto, CA, USA), can deliver treatments faster than GK treatments for a variety of reasons, including a dose delivery rate that is at least six times faster, as well as the ability to treat multiple metastases simultaneously, rather than sequentially. The treatments can also be completed using frameless immobilization—without affixing the patient's skull to an immobilization frame—as required for most GK treatments.
Related Links:
University of Alabama at Birmingham
Varian Medical Systems
Researchers at the University of Alabama at Birmingham (UAB; USA) identified 20 previously treated Gamma Knife (GK) cases involving a total of 112 lesions, and re-planned them using single fraction VMAT RapidArc radiosurgery. The approach is based on using key RapidArc features, including a high-definition multileaf collimator for ultra-fine beam shaping; a high intensity mode for delivering high doses quickly; and jaw tracking technology for extra shielding of normal tissues.
The UAB approach to RapidArc planning calls for the beam to be delivered using non-coplanar arcs or rotations to maximize the number of treatment angles and enhance precision, as well as optimization criteria that minimizes the amount of low dose fall-off reaching normal brain tissues during treatment. The researchers also developed a predictive model of the 12Gy isodose volume as a function of tumor number and volume.
The results showed that the RapidArc treatment plans for treating multiple tumors are comparable to GK plans in terms of how precisely they can match high doses to the shape of the targeted tumors, as well as minimizing exposure of normal brain tissue outside the treatment area. The researchers also noted that RapidArc treatment for multiple metastases can be completed in 22 minutes, while a comparable GK treatment might take one to five hours, depending on the number of metastases. The study was published in the October 2014 issue of Neurosurgery.
“Brain metastases impact some 170,000 cancer patients in the US each year, and over 70% of those cases involve multiple metastases,” said senior author Prof. John Fiveash, MD, vice chairman for academic programs at UAB. “Using Varian's latest medical linear accelerators and RapidArc technology for VMAT, we can devise treatments that offer the same level of conformity as Gamma Knife technology.”
The RapidArc Radiosurgery system, a product of Varian Medical Systems (Palo Alto, CA, USA), can deliver treatments faster than GK treatments for a variety of reasons, including a dose delivery rate that is at least six times faster, as well as the ability to treat multiple metastases simultaneously, rather than sequentially. The treatments can also be completed using frameless immobilization—without affixing the patient's skull to an immobilization frame—as required for most GK treatments.
Related Links:
University of Alabama at Birmingham
Varian Medical Systems
Read the full article by registering today, it's FREE!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
- Free digital version edition of Medical Imaging International sent by email on regular basis
- Free print version of Medical Imaging International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of Medical Imaging International in digital format
- Free Medical Imaging International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment